Form 4: HeartBeam Director Reports Equity Grants
Insider Transaction Report
HeartBeam Director Kenneth Warwick Nelson III reported the grant of 75,634 Restricted Stock Units (RSUs) and beneficial ownership of 127,147 common shares.
Summary
- Kenneth Warwick Nelson III, a Director of HeartBeam, Inc. (BEAT), reported changes in his beneficial ownership.
- Beneficially owns 127,147 shares of HeartBeam Common Stock following the reported transactions.
- Received a grant of 60,483 Restricted Stock Units (RSUs) on July 11, 2025, which are scheduled to vest 100% on the earlier of July 11, 2026, or the Issuer's 2026 annual meeting of stockholders, contingent on continued service as an Outside Director.
- Received an additional grant of 15,151 Restricted Stock Units (RSUs) on September 30, 2025, with one-half vesting on October 1, 2025 (three-month anniversary of July 1, 2025 vesting commencement date) and the remaining half vesting on January 1, 2026 (six-month anniversary).
- All RSU grants were issued from the Company's 2022 Equity Incentive Plan.
Sentiment
Score: 6
Explanation: The filing reports routine equity compensation for a director, which is generally viewed as a neutral to slightly positive event as it aligns insider interests with shareholder value. It does not contain information that would significantly alter the company's fundamental outlook.
Positives
- The grant of Restricted Stock Units to a director aligns management's long-term interests with those of shareholders, promoting retention and performance.
- The equity incentive plan demonstrates a structured approach to executive and director compensation.
Future Outlook
The future outlook primarily involves the vesting of the granted Restricted Stock Units on their respective schedules, aligning the director's compensation with the company's future performance and continued service.
Industry Context
The grant of Restricted Stock Units to a director is a common practice in publicly traded companies, particularly in the technology and healthcare sectors, to incentivize long-term commitment and align leadership interests with shareholder value creation.
Related Party Transactions
- Grant of 60,483 Restricted Stock Units (RSUs) to Director Kenneth Warwick Nelson III on July 11, 2025, as compensation.
- Grant of 15,151 Restricted Stock Units (RSUs) to Director Kenneth Warwick Nelson III on September 30, 2025, as compensation.
Stakeholder Impact
- Shareholders: The equity grants align the director's financial interests with the long-term performance of the company, potentially fostering better governance and strategic decisions.
Next Steps
- Vesting of 60,483 RSUs on the earlier of July 11, 2026, or the 2026 annual meeting of stockholders.
- Vesting of the remaining half of 15,151 Special RSUs on January 1, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Vesting commencement date for the 15,151 Special RSUs. |
| 07/11/2025 | Grant date for 60,483 Restricted Stock Units (RSUs). |
| 09/30/2025 | Grant date for 15,151 Restricted Stock Units (RSUs). |
| 10/01/2025 | Vesting date for one-half of the 15,151 Special RSUs. |
| 10/02/2025 | Signature date of the Form 4 filing. |
| 01/01/2026 | Vesting date for the remaining half of the 15,151 Special RSUs. |
| 07/11/2026 | Earliest vesting date for the 60,483 RSUs. |
| 2026 annual meeting | Latest vesting date for the 60,483 RSUs, if earlier than July 11, 2026. |
Keywords
HeartBeam, BEAT, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Kenneth Warwick Nelson III
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.